Canada markets closed

InnoCan Pharma Corporation (IP4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1800+0.0195 (+12.15%)
At close: 06:23PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 47.36M
Enterprise Value 43.14M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.72
Price/Book (mrq)13.36
Enterprise Value/Revenue 2.49
Enterprise Value/EBITDA -12.40

Trading Information

Stock Price History

Beta (5Y Monthly) 3.09
52-Week Change 319.84%
S&P500 52-Week Change 324.16%
52 Week High 30.3500
52 Week Low 30.1254
50-Day Moving Average 30.1853
200-Day Moving Average 30.2034

Share Statistics

Avg Vol (3 month) 349.97k
Avg Vol (10 day) 312.45k
Shares Outstanding 5280.66M
Implied Shares Outstanding 6296.34M
Float 8217.4M
% Held by Insiders 122.96%
% Held by Institutions 10.19%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin -27.55%
Operating Margin (ttm)-17.91%

Management Effectiveness

Return on Assets (ttm)-30.36%
Return on Equity (ttm)-89.07%

Income Statement

Revenue (ttm)18.86M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)333.80%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-5.2M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.59M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)7k
Total Debt/Equity (mrq)0.15%
Current Ratio (mrq)2.06
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-3.49M
Levered Free Cash Flow (ttm)690.38k